October is Breast Cancer Awareness Month. There is good news for women fighting bone-loss after treatment.
The bone density drug Zoledronic Acid is prescribed to fight Osteoporosis especially in post-menopausal women.
It has been given to breast cancer patients for the same reasons.
Now, in a new study published in the journal cancer, researchers say
the drug is doing its job.
Patients took the drug both at the start of their breast cancer therapy and others waited 36 months after starting treatment.
Taking the drug at the start protected against bone loss in the lower
spine and hip.
Copyright 2011 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
After two years of working to build Maryland Health Connection, Executive Director Rebecca Pearce has resigned.
This is a study that might make moms pretty mad. According to the University of South Carolina’s Arnold School of Public Health, modern moms are spending more time watching television and less time doing housework.
After dealing with consistent pain for years, a Bel Air mom takes a drastic step to remove a popular form of birth control from her body.